Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Pharmacopeia achieves milestone in Schering collaboration

Jan. 18, 2000

Isis and AstraZeneca establish antisense target validation program

Jan. 17, 2000

Ares-Serono and Alkermes to collaborate on sustained-release formulations of proteins

Jan. 14, 2000

Lexicon Genetics and Scripps Institute announce functional genomics agreement

Jan. 14, 2000

Alexion signs transgenic agreement with Genzyme Transgenics

Jan. 14, 2000

Abgenix and Elan enter antibody collaboration for neurological diseases

Jan. 13, 2000

AstraZeneca enters agreement with Vion/EPTTCO for cancer drug delivery technology

Jan. 12, 2000

Strategic alliance formed between Medarex and Kirin Brewery

Jan. 12, 2000

OSI Pharmaceuticals licenses gene transcription patent estate to R.W. Johnson

Jan. 12, 2000

Organon signs exclusive agreement with CIMA

Jan. 11, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...